Anti-inflammatory effects of Zingiber officinale in type 2 diabetic patients

Advanced Pharmaceutical Bulletin

Volumn 3, Issue 2, 2013, Pages 273-276

  Mahluji, Sepide ^a   Ostadrahimi, Alireza ^b   Mobasseri, Majid ^c   Attari, Vahide Ebrahimzade ^a   Payahoo, Laleh ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Ginger; Inflammation; TNF

Indexed keywords

C REACTIVE PROTEIN; HERBACEOUS AGENT; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; FEMALE; GINGER; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POWDER; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 84885783202     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.5681/apb.2013.044     Document Type: Article

References (21)

1. Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 2008;46(2):409-20.
2. Srivastava KC, Mustafa T. Ginger (zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses 1992;39(4):342-8.
3. Bryer E. A literature review of the effectiveness of ginger in alleviating mild-to-moderate nausea and vomiting of pregnancy. J Midwifery Womens Health 2005;50(1):e1-3.
4. Leach MJ, Kumar S. The clinical effectiveness of ginger (zingiber officinale) in adults with osteoarthritis. Int J Evid Based Healthc 2008;6(3):311-20.
5. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 2001;44(11):2531-8.
6. Mustafa T, Srivastava KC. Ginger (Zingiber officinale) in migraine headache. J Ethnopharmacol 1990;29(3):267-73.
7. Shukla Y, Singh M. Cancer preventive properties of ginger: A brief review. Food Chem Toxicol 2007;45(5):683-90.
8. White B. Ginger: An overview. Am Fam Physician 2007;75(11):1689-91.
9. Grzanna R, Lindmark L, Frondoza CG. Ginger-an herbal medicinal product with broad anti-inflammatory actions. J Med Food 2005;8(2):125-32.
10. Grzanna R, Phan P, Polotsky A, Lindmark L, Frondoza CG. Ginger extract inhibits ß-amyloid peptide-induced cytokine and chemokine expression in cultured thp-1 monocytes. J Altern Complement Med 2004;10(6):1009-1013.
11. Charlier C, Michaux C. Dual inhibition of cyclooxygenase-2 (cox-2) and 5-lipoxygenase (5-lox) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. Eur J Med Chem 2003;38(7-8):645-59.
12. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based european prospective investigation into cancer and nutrition (epic)-potsdam study. Diabetes 2003;52(3):812-7.
13. Ray A, Huisman MV, Tamsma JT, van Asten J, Bingen BO, Broeders EA, et al. The role of inflammation on atherosclerosis, intermediate and clinical cardiovascular endpoints in type 2 diabetes mellitus. Eur J Intern Med 2009;20(3):253-60.
14. Fatehi-Hassanabad Z, Gholamnezhad Z, Jafarzadeh M, Fatehi M. The anti-inflammatory effects of aqueous extract of ginger root in diabetic mice. DARU J Pharm Sci 2005;13(2):70-3.
15. Morakinyo OA, Akindele AJJ, Ahmned Z. Modulation of antioxidant enzymes and inflammatory cytokines: possible mechanism of antidiabetic effect of ginger extracts. Afr J Biomed Res 2011;14(3):195-202.
16. Alizadeh-Navaei R, Roozbeh F, Saravi M, Pouramir M, Jalali F, Moghadamnia AA. Investigation of the effect of ginger on the lipid levels: A double blind controlled clinical trial. Saudi Med J 2008;29(9):1280-4.
17. Zar JH. Biostatistical analysis. 4th ed. New Jersey: Prentice Hall;1999.
18. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286(3):327-34.
19. Festa A, D'Agostino R, Jr., Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study (iras). Circulation 2000;102(1):42-7.
20. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009;94(9):3171-82
21. Ramadan G, Al-Kahtani MA, El-Sayed WM. Anti-inflammatory and anti-oxidant properties of curcuma longa (turmeric) versus zingiber officinale (ginger) rhizomes in rat adjuvant-induced arthritis. Inflammation 2011;34(4):291-301.